Analysis of the 2021 ESC/EACTS Guidelines for the Management of Valvular Heart Disease

Published:January 09, 2023DOI:


      The evaluation and management of valvular heart disease varies based on the valve-specific pathology, severity, and symptomatology, and treatment ranges from medical management to surgical correction. Given the heterogeneity and complexity of management, the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS) provided an updated guideline in 2021 to facilitate decision making. The expert consensus guideline includes updated commentary about valvular epidemiology, best practice interventions, advanced imaging, anti-thrombosis, risk stratification, and other valve-specific recommendations. The aim of this analysis is to review, abridge, validate, and critique the expert consensus guidelines with emphasis on the evaluation and treatment of aortic stenosis, aortic insufficiency, mitral regurgitation, mitral stenosis, and tricuspid regurgitation.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Cardiothoracic and Vascular Anesthesia
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect